APRETUDE

Apretude

Apretude

(cabotegravir long-acting for PrEP)

Apretude is an HIV-1 integrase strand transfer inhibitor (INSTI).

Prescribing Information, including boxed warning

Patient Information

Stability Tool

Implementation Resources

Telehealth Delivery of Cabotegravir LA for PrEP

APRETUDE Implementation Guidance for Clinics

Long-Acting Agent Resource Center

WHO PrEP Implementation Tool

Long-Acting Injectable PrEP | NASTAD

Long-Acting Injectable PrEP is Here: Frequently Asked Questions (FAQs) for Implementation | NSTAD

Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), and Other HIV Prevention Strategies: Billing and Coding Guide | NASTAD

HPTN 083 website

HPTN 084 website

How Community Engagement Helped Shape the Eboni Study

Making CAB LA PrEP Implementation Work for You: Findings from the Pillar Study

Implementation Podcast series

Flexible Scheduling

Drop-In Injection Visits Guidance

Prescheduled Appointment Guidance

Designated Injection Days Guidance

How to Discuss Sex Health

How to Discuss Sexual Health Guidance

Implementation Guidance

Related links

Learn more about PrEP

Registrational Trials